TAG:
LabCorp
Labcorp: Ascension Deal Will Earn $550 Million in 2023
By Robert Michel | From the Volume XXX No. 4 – March 6, 2023 Issue
PUBLICLY TRADED LABORATORY COMPANIES OFFERED INSIGHTS into how acquisitions of hospital lab operations and outreach businesses add to their bottom lines, according to recent reports on full-year 2022 and fourth quarter earnings. Last year was a busy one…
Pandemic Helped Lab with Hospital Leaders
By Scott Wallask | From the Volume XXX No. 3 – February 13, 2023 Issue
CEO SUMMARY: Growth at Atrium Health during the COVID-19 pandemic elevated its clinical laboratory’s profile with medical leaders and health system administrators. What followed was a new spirit of collaboration that led to lab involvement in cost savings efforts, such as improved…
Lab Accreditors CAP and Joint Commission Face Inspector Hiring Pressures
By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue
In an exclusive story, The Dark Report covers the difficulties facing lab accreditors the College of American Pathologists (CAP) and The Joint Commission (TJC) in staffing inspection and survey teams under CLIA. Like the clinical laboratories they accredit to the requirem…
Labcorp to Pay $19m to Settle Whistleblower Allegations
By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue
LABCORP AGREED TO SETTLE WHISTLEBLOWER ALLEGATIONS that it violated the False Claims Act by allowing its phlebotomists to draw blood from patients when the company allegedly knew kickbacks were behind the test orders for other lab firms. As part of the settlement, Labcorp in Burli…
Labcorp Selects Oracle Cerner to Streamline Lab Workflows
By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue
THERE IS A UNIQUE CORPORATE COLLABORATION unfolding that involves Labcorp and Oracle Cerner. Announced in November, Labcorp will use Oracle Cerner’s lab information systems to update clinical laboratory workflow processes and support the sharing of patient data across healthcare organ…
Analytics Lets Labs Offset Staffing Woes
By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue
CEO SUMMARY: For hospital laboratories confronting worker shortages, data analytics can be useful for improving workflows and determining effective staffing levels. This information can also induce changes that may improve employee morale. Two experts discuss three analytics reports…
Babson Diagnostics’ Hybrid Model Combines Quality, Convenience
By Robert Michel | From the Volume XXIX, No. 16 – November 21, 2022 Issue
CEO SUMMARY: Responding to its own data about consumer preferences, healthcare technology company Babson Diagnostics is pursuing a new hybrid model for blood draws that it believes brings together the best of clinical laboratories and retail pharmacies. Laboratory managers and patho…
October 31, 2022, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 15 – October 31, 2022 Issue
Clinical laboratories may soon face increasing pressure to test for respiratory syncytial virus (RSV) now that the public has become aware of the pathogen. Over the past month, there has been an onslaught of media attention on RSV. The coverage has often focused on how this common virus could tag…
Ravgen Gets $272.5 Million Verdict against Labcorp
By Scott Wallask | From the Volume XXIX, No. 15 – October 31, 2022 Issue
CEO SUMMARY: In September, a jury returned a $272.5 million verdict against Labcorp, representing royalties owed to biotech company Ravgen for infringement of its diagnostic genetic test patent. Soon after, Quest Diagnostics settled a similar lawsuit with Ravgen before its tri…
Newsmaker Interview: Director of CDC’s Division of Laboratory Systems Talks COVID-19, CLIA, and More
By Robert Michel | From the Volume XXIX, No. 15 – October 31, 2022 Issue
CEO SUMMARY: In this exclusive interview, Reynolds Salerno, PhD, the Director of the Division of Laboratory Systems at the CDC, offers insightful comments about the federal agency’s response to the SARS-CoV-2 pandemic, what went right during public health efforts, and lesson…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized